Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality

A systematic review

Chris Fox, Toby Smith, Ian Maidment, Wei Yee Chan, Nelson Bua, Phyo Kyaw Myint, Malaz Boustani, Chun Shing Kwok, Michelle Glover, Imogen Koopmans, Noll Campbell

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Objectives: to determine the effect of drugs with anti-cholinergic properties on relevant health outcomes.Design: electronic published and unpublished literature/trial registries were systematically reviewed. Studies evaluating medications with anti-cholinergic activity on cognitive function, delirium, physical function or mortality were eligible.Results: forty-six studies including 60,944 participants were included. Seventy-seven percent of included studies evaluating cognitive function (n = 33) reported a significant decline in cognitive ability with increasing anti-cholinergic load (P < 0.05). Four of five included studies reported no association with delirium and increasing anti-cholinergic drug load (P > 0.05). Five of the eight included studies reported a decline in physical function in users of anti-cholinergics (P < 0.05). Three of nine studies evaluating mortality reported that the use of drugs with anti-cholinergic properties was associated with a trend towards increased mortality, but this was not statistically significant. The methodological quality of the evidence-base ranged from poor to very good.Conclusion: medicines with anti-cholinergic properties have a significant adverse effect on cognitive and physical function, but limited evidence exists for delirium or mortality outcomes.

Original languageEnglish
Article numberafu096
Pages (from-to)604-615
Number of pages12
JournalAge and Ageing
Volume43
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Delirium
Cholinergic Antagonists
Cognition
Mortality
Aptitude
Pharmaceutical Preparations
Registries
Health

Keywords

  • Adverse effect
  • Anti-cholinergic
  • Anti-muscarinic
  • Cholinergic antagonist
  • Cognition
  • Function
  • Mortality
  • Older people
  • Systematic review

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Cite this

Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality : A systematic review. / Fox, Chris; Smith, Toby; Maidment, Ian; Chan, Wei Yee; Bua, Nelson; Myint, Phyo Kyaw; Boustani, Malaz; Kwok, Chun Shing; Glover, Michelle; Koopmans, Imogen; Campbell, Noll.

In: Age and Ageing, Vol. 43, No. 5, afu096, 2014, p. 604-615.

Research output: Contribution to journalArticle

Fox, C, Smith, T, Maidment, I, Chan, WY, Bua, N, Myint, PK, Boustani, M, Kwok, CS, Glover, M, Koopmans, I & Campbell, N 2014, 'Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: A systematic review', Age and Ageing, vol. 43, no. 5, afu096, pp. 604-615. https://doi.org/10.1093/ageing/afu096
Fox, Chris ; Smith, Toby ; Maidment, Ian ; Chan, Wei Yee ; Bua, Nelson ; Myint, Phyo Kyaw ; Boustani, Malaz ; Kwok, Chun Shing ; Glover, Michelle ; Koopmans, Imogen ; Campbell, Noll. / Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality : A systematic review. In: Age and Ageing. 2014 ; Vol. 43, No. 5. pp. 604-615.
@article{a0c1a935d0094abb9f19659ee81c0ef5,
title = "Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: A systematic review",
abstract = "Objectives: to determine the effect of drugs with anti-cholinergic properties on relevant health outcomes.Design: electronic published and unpublished literature/trial registries were systematically reviewed. Studies evaluating medications with anti-cholinergic activity on cognitive function, delirium, physical function or mortality were eligible.Results: forty-six studies including 60,944 participants were included. Seventy-seven percent of included studies evaluating cognitive function (n = 33) reported a significant decline in cognitive ability with increasing anti-cholinergic load (P < 0.05). Four of five included studies reported no association with delirium and increasing anti-cholinergic drug load (P > 0.05). Five of the eight included studies reported a decline in physical function in users of anti-cholinergics (P < 0.05). Three of nine studies evaluating mortality reported that the use of drugs with anti-cholinergic properties was associated with a trend towards increased mortality, but this was not statistically significant. The methodological quality of the evidence-base ranged from poor to very good.Conclusion: medicines with anti-cholinergic properties have a significant adverse effect on cognitive and physical function, but limited evidence exists for delirium or mortality outcomes.",
keywords = "Adverse effect, Anti-cholinergic, Anti-muscarinic, Cholinergic antagonist, Cognition, Function, Mortality, Older people, Systematic review",
author = "Chris Fox and Toby Smith and Ian Maidment and Chan, {Wei Yee} and Nelson Bua and Myint, {Phyo Kyaw} and Malaz Boustani and Kwok, {Chun Shing} and Michelle Glover and Imogen Koopmans and Noll Campbell",
year = "2014",
doi = "10.1093/ageing/afu096",
language = "English",
volume = "43",
pages = "604--615",
journal = "Age and Ageing",
issn = "0002-0729",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality

T2 - A systematic review

AU - Fox, Chris

AU - Smith, Toby

AU - Maidment, Ian

AU - Chan, Wei Yee

AU - Bua, Nelson

AU - Myint, Phyo Kyaw

AU - Boustani, Malaz

AU - Kwok, Chun Shing

AU - Glover, Michelle

AU - Koopmans, Imogen

AU - Campbell, Noll

PY - 2014

Y1 - 2014

N2 - Objectives: to determine the effect of drugs with anti-cholinergic properties on relevant health outcomes.Design: electronic published and unpublished literature/trial registries were systematically reviewed. Studies evaluating medications with anti-cholinergic activity on cognitive function, delirium, physical function or mortality were eligible.Results: forty-six studies including 60,944 participants were included. Seventy-seven percent of included studies evaluating cognitive function (n = 33) reported a significant decline in cognitive ability with increasing anti-cholinergic load (P < 0.05). Four of five included studies reported no association with delirium and increasing anti-cholinergic drug load (P > 0.05). Five of the eight included studies reported a decline in physical function in users of anti-cholinergics (P < 0.05). Three of nine studies evaluating mortality reported that the use of drugs with anti-cholinergic properties was associated with a trend towards increased mortality, but this was not statistically significant. The methodological quality of the evidence-base ranged from poor to very good.Conclusion: medicines with anti-cholinergic properties have a significant adverse effect on cognitive and physical function, but limited evidence exists for delirium or mortality outcomes.

AB - Objectives: to determine the effect of drugs with anti-cholinergic properties on relevant health outcomes.Design: electronic published and unpublished literature/trial registries were systematically reviewed. Studies evaluating medications with anti-cholinergic activity on cognitive function, delirium, physical function or mortality were eligible.Results: forty-six studies including 60,944 participants were included. Seventy-seven percent of included studies evaluating cognitive function (n = 33) reported a significant decline in cognitive ability with increasing anti-cholinergic load (P < 0.05). Four of five included studies reported no association with delirium and increasing anti-cholinergic drug load (P > 0.05). Five of the eight included studies reported a decline in physical function in users of anti-cholinergics (P < 0.05). Three of nine studies evaluating mortality reported that the use of drugs with anti-cholinergic properties was associated with a trend towards increased mortality, but this was not statistically significant. The methodological quality of the evidence-base ranged from poor to very good.Conclusion: medicines with anti-cholinergic properties have a significant adverse effect on cognitive and physical function, but limited evidence exists for delirium or mortality outcomes.

KW - Adverse effect

KW - Anti-cholinergic

KW - Anti-muscarinic

KW - Cholinergic antagonist

KW - Cognition

KW - Function

KW - Mortality

KW - Older people

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=84906877927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906877927&partnerID=8YFLogxK

U2 - 10.1093/ageing/afu096

DO - 10.1093/ageing/afu096

M3 - Article

VL - 43

SP - 604

EP - 615

JO - Age and Ageing

JF - Age and Ageing

SN - 0002-0729

IS - 5

M1 - afu096

ER -